547 The Phase III trial of olpasiran aims to compare its effects with the placebo on the risk of coronary heart disease death, myocardial infarction, and urgent coronary revascularization in ASCVD patients with elevated Lp(a), with results expected by 2026 (NCT05581303)
Nutrients, minerals, antioxidant pigments and phytochemicals, and antioxidant capacity of the leaves of stem amaranth
Research explores its use for arthritis, heart disease, and brain disorders
BPC-157 occupies a complex regulatory space
Human embryonic stem cell-derived exosomes promote pressure ulcer healing in aged mice by rejuvenating senescent endothelial cells
Bavishi Fertility Institute is dedicated to providing customised and personalised treatments which are simple, safe , smart and successful